Study Evaluating CMP-001 in Combination With Atezolizumab in Participants With Non-Small Cell Lung Cancer
Clinical trial NCT03438318 · COMPLETED
Trial details
- NCT number
- NCT03438318
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-15
- Primary completion
- 2019-12-11
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.